The NAFLD mouse model produced similar outcomes to the human patients, demonstrating a positive correlation between FC and ALT in both the liver tissue and plasma (Figure 1E, F). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.